skip to Main Content
World AIDS Day

World AIDS Day

Today we remember and support #WorldAIDSDay. Medical research has seen amazing advances and milestones over the past few decades. Here at IRBM, we are proud to have played a major role in the discovery of Raltegravir (Isentress) while part of Merck & Co, for the treatment of #HIV-1 infection in combination with other antiretroviral agents.
COVID-19 And Vaccines. A Race Of Three (plus Two)

COVID-19 and vaccines. A race of three (plus two)

According to the World Health Organization, there are 48 vaccine candidates in clinical trials and 164, still in the pre-clinical testing phase. Let’s analyze efficacy, safety and timing of the three the protagonists of this race.

World Vaccine Congress Washington 2019

Stefania Di Marco, Ph.D., Qualified Person of ADVENT, and Daniel Conlon, IRBM’s VP of Business Development, North America, will be attending the World Vaccine Congress in Washington, D.C. from April 14 to April 17. To learn more about ADVENT’s capabilities,…


World Vaccine Congress Europe 2019

From October 19-21, ADVENT’s Qualified Person, Dr. Stefania di Marco, will attend the World Vaccine Congress Europe 2019 in Barcelona, Spain. She will be joined by Heidi Kingdon Jones, IRBM’s Global VP of Sales and Marketing. To learn more about…

32nd International Conference On Vaccines And Immunization

32nd International Conference on Vaccines and Immunization

Pier Giorgio Pacifici, Ph.D., IRBM’s Business Development Manager, and Stefania Di Marco, PhD, QP of ADVENT, will be attending the International Conference on Vaccines and Immunization in Rome on March 21st-22nd. The event unites renowned vaccination and immunology researchers to…

Back To Top